DaVita Inc
NYSE:DVA
Relative Value
The Relative Value of one
DVA
stock under the Base Case scenario is
294.62
USD.
Compared to the current market price of 149.96 USD,
DaVita Inc
is
Undervalued by 49%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
DVA Competitors Multiples
DaVita Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
DaVita Inc
NYSE:DVA
|
10.5B USD | 0.8 | 13.8 | 7.2 | 9.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.5B USD | 0.2 | 55.4 | 14.1 | 14.1 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.2B EUR | 0.3 | 13.3 | 7.8 | 9.9 | |
| US |
|
Cigna Corp
NYSE:CI
|
71B USD | 0.3 | 11.6 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.3B EUR | 1.2 | 21.5 | 10 | 14.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.9B EUR | 1.2 | 23.4 | 9 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD | 1.6 | 25.6 | 12.3 | 17.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.2B USD | 2 | 22.5 | 12.4 | 16.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 11.3 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.9B USD | 12.1 | -28.6 | -30.7 | -27.9 | |
| US |
|
Brightspring Health Services Inc
NASDAQ:BTSG
|
8.1B USD | 0 | 0 | 0 | 0 |